6H-furo[3,4-c][1,2,5]oxadiazol-4-one 、 5-氯-2-甲基苄胺 在
氯仿 作用下,
以
氯仿 为溶剂,
反应 16.0h,
以to give the desired product as a white powder (750 mg, 67%)的产率得到N-(5-chloro-2-methylbenzyl)-4-(hydroxymethyl)-1,2,5-oxadiazole-3-carboxamide
参考文献:
名称:
N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
申请人:Combs Andrew P.
公开号:US20080182882A1
公开(公告)日:2008-07-31
The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods of use thereof related to the treatment of cancer and other diseases.
[EN] N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE<br/>[FR] N-HYDROXYAMIDINOHÉTÉROCYCLES UTILISÉS COMME MODULATEURS DE L'INDOLEAMINE 2,3-DIOXYGÉNASE
申请人:INCYTE CORP
公开号:WO2008058178A1
公开(公告)日:2008-05-15
[EN] The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods of use thereof related to the treatment of cancer and other diseases. Formula (I). [FR] La présente invention concerne des modulateurs de l'indoleamine 2,3-dioxygénase (IDO) représentés par la formule (I), ainsi que des compositions pharmaceutiques contenant ces modulateurs et des procédés d'utilisation de ceux-ci en relation avec le traitement du cancer et d'autres maladies.